Cellceutix Corp. has selected Dr. Reddy’s Laboratories to manufacture Prurisol, its new drug candidate for the treatment of psoriasis. Dr. Reddy’s will manufacture Prurisol for oral dosing for Phase II/III trials, which will begin upon completion of the manufacturing.   “We have great expectations for this drug because it performed amazingly in lab studies. Our research showed Prurisol to be much more effective than methotrexate, a standard of care treatment for advanced psoria...